PTC Therapeutics
PTCT
$32.13
Share price
12.46%
Change (1 day)
-41.73%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - P/B ratio
P/B ratio as of April 2024 : -2.67
According to PTC Therapeutics
's latest financial reports the company has a price-to-book ratio of -2.67.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
PTC Therapeutics - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -2.54 | -68.34% |
| 2022-12-31 | -8.03 | -100.41% |
| 2021-12-31 | > 1000 | 22563.84% |
| 2020-12-31 | 8.64 | 72.62% |
| 2019-12-31 | 5.01 | 1.08% |
| 2018-12-31 | 4.95 | 11.94% |
| 2017-12-31 | 4.42 | 41.29% |
| 2016-12-31 | 3.13 | -35.61% |
| 2015-12-31 | 4.86 | -14.79% |
| 2014-12-31 | 5.71 | 92.89% |
| 2013-12-31 | 2.96 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 5.03 | -288.24% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | 5.84 | -318.55% | 🇺🇸 USA |
 Xencor XNCR | 1.84 | -168.84% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 14.2 | -629.63% | 🇺🇸 USA |
 Fate Therapeutics
FATE | 1.17 | -143.89% | 🇺🇸 USA |
 Avidity Biosciences RNA | 3.88 | -245.03% | 🇺🇸 USA |